Hannedouche T, Godin M, Fries D, Fillastre J P
Department of Nephrology, Hôpital de Bois-Guillaume, Paris, France.
Nephron. 1991;57(2):230-1. doi: 10.1159/000186257.
Acute reversible renal failure is a widely recognized potential complication of angiotensin-converting enzyme inhibitor (ACEI) administration in renovascular hypertension, particularly in bilateral artery stenosis or stenosis involving a solitary kidney. We report herein 2 cases of a rare but severe complication, i.e., acute renal artery thrombosis. Whereas marked hypotension does not seem to be necessary to trigger acute renal failure following ACE inhibition, by contrast, the fall in blood pressure could play an important role in our patients. Since single-dose ACEI has been advocated in order to improve the predictive value of renal scintigraphy or plasma renin activity measurements in the diagnosis of renovascular hypertension, the potential risk of this approach should be stressed.
急性可逆性肾衰竭是血管紧张素转换酶抑制剂(ACEI)用于治疗肾血管性高血压时一种广为人知的潜在并发症,尤其是在双侧动脉狭窄或累及单肾的狭窄情况下。我们在此报告2例罕见但严重的并发症,即急性肾动脉血栓形成。虽然ACE抑制后引发急性肾衰竭似乎并不一定需要显著低血压,但相比之下,血压下降在我们的患者中可能起重要作用。由于提倡使用单剂量ACEI以提高肾闪烁显像或血浆肾素活性测量在肾血管性高血压诊断中的预测价值,因此应强调这种方法的潜在风险。